Natixis Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.1M | Buy |
254,716
+54,909
| +27% | +$2.98M | 0.02% | 588 |
|
|
2025
Q4 | $9.8M | Sell |
199,807
-153,192
| -43% | -$7.14M | 0.01% | 658 |
|
|
2025
Q3 | $15.2M | Sell |
352,999
-1,992
| -0.6% | -$77.8K | 0.02% | 559 |
|
|
2025
Q2 | $13.6M | Sell |
354,991
-12,054
| -3% | -$461K | 0.02% | 592 |
|
|
2025
Q1 | $14.2M | Buy |
367,045
+23,711
| +7% | +$868K | 0.03% | 549 |
|
|
2024
Q4 | $11.6M | Sell |
343,334
-157,161
| -31% | -$5.66M | 0.02% | 607 |
|
|
2024
Q3 | $20.5M | Buy |
500,495
+83,433
| +20% | +$3.41M | 0.04% | 417 |
|
|
2024
Q2 | $16.1M | Buy |
417,062
+39,346
| +10% | +$1.66M | 0.03% | 457 |
|
|
2024
Q1 | $16.2M | Buy |
377,716
+52,040
| +16% | +$2.15M | 0.04% | 453 |
|
|
2023
Q4 | $12.1M | Buy |
325,676
+31,566
| +11% | +$1.13M | 0.03% | 508 |
|
|
2023
Q3 | $10.7M | Buy |
294,110
+51,922
| +21% | +$1.84M | 0.03% | 491 |
|
|
2023
Q2 | $8.63M | Buy |
242,188
+31,342
| +15% | +$1.12M | 0.03% | 568 |
|
|
2023
Q1 | $7.5M | Buy |
210,846
+43,011
| +26% | +$1.5M | 0.03% | 589 |
|
|
2022
Q4 | $5.9M | Sell |
167,835
-54,892
| -25% | -$1.83M | 0.02% | 637 |
|
|
2022
Q3 | $6.55M | Sell |
222,727
-63,663
| -22% | -$2.41M | 0.03% | 554 |
|
|
2022
Q2 | $15.9M | Buy |
286,390
+41,043
| +17% | +$2.27M | 0.07% | 329 |
|
|
2022
Q1 | $13.4M | Buy |
245,347
+55,284
| +29% | +$3M | 0.05% | 383 |
|
|
2021
Q4 | $10.5M | Sell |
190,063
-36,962
| -16% | -$1.92M | 0.04% | 451 |
|
|
2021
Q3 | $10.8M | Buy |
227,025
+6,122
| +3% | +$308K | 0.04% | 397 |
|
|
2021
Q2 | $11M | Buy |
220,903
+4,594
| +2% | +$221K | 0.05% | 391 |
|
|
2021
Q1 | $9.65M | Sell |
216,309
-48,548
| -18% | -$2.2M | 0.05% | 398 |
|
|
2020
Q4 | $12.2M | Sell |
264,857
-114,641
| -30% | -$5.27M | 0.07% | 310 |
|
|
2020
Q3 | $17.9M | Sell |
379,498
-18,107
| -5% | -$907K | 0.11% | 214 |
|
|
2020
Q2 | $20.3M | Sell |
397,605
-114,988
| -22% | -$5.9M | 0.13% | 184 |
|
|
2020
Q1 | $24.3M | Buy |
512,593
+9,995
| +2% | +$533K | 0.2% | 113 |
|
|
2019
Q4 | $29.5M | Buy |
502,598
+17,330
| +4% | +$964K | 0.21% | 107 |
|
|
2019
Q3 | $25.9M | Buy |
485,268
+21,204
| +5% | +$1.09M | 0.21% | 117 |
|
|
2019
Q2 | $23.2M | Buy |
464,064
+12,896
| +3% | +$647K | 0.19% | 125 |
|
|
2019
Q1 | $23.6M | Buy |
451,168
+34,815
| +8% | +$1.74M | 0.21% | 108 |
|
|
2018
Q4 | $19.9M | Sell |
416,353
-20,514
| -5% | -$1.01M | 0.2% | 110 |
|
|
2018
Q3 | $21.9M | Buy |
436,867
+16,513
| +4% | +$839K | 0.19% | 112 |
|
|
2018
Q2 | $21.2M | Buy |
420,354
+20,006
| +5% | +$1.01M | 0.2% | 104 |
|
|
2018
Q1 | $19.6M | Buy |
400,348
+86,445
| +28% | +$4.03M | 0.19% | 109 |
|
|
2017
Q4 | $13.9M | Sell |
313,903
-77,556
| -20% | -$3.58M | 0.14% | 171 |
|
|
2017
Q3 | $19.9M | Sell |
391,459
-947
| -0.2% | -$48K | 0.21% | 106 |
|
|
2017
Q2 | $21.2M | Sell |
392,406
-4,241
| -1% | -$226K | 0.23% | 86 |
|
|
2017
Q1 | $20.9M | Buy |
396,647
+49,201
| +14% | +$2.5M | 0.23% | 84 |
|
|
2016
Q4 | $16.7M | Sell |
347,446
-41,568
| -11% | -$2.05M | 0.2% | 116 |
|
|
2016
Q3 | $21M | Buy |
389,014
+23,296
| +6% | +$1.28M | 0.27% | 78 |
|
|
2016
Q2 | $19.8M | Buy |
365,718
+39,346
| +12% | +$2.07M | 0.27% | 82 |
|
|
2016
Q1 | $16.5M | Buy |
326,372
+38,995
| +14% | +$1.94M | 0.25% | 87 |
|
|
2015
Q4 | $14.5M | Buy |
287,377
+20,126
| +8% | +$1.03M | 0.24% | 80 |
|
|
2015
Q3 | $12.8M | Buy |
267,251
+10,159
| +4% | +$529K | 0.22% | 90 |
|
|
2015
Q2 | $13.4M | Sell |
257,092
-39,999
| -13% | -$2.25M | 0.23% | 95 |
|
|
2015
Q1 | $17.1M | Buy |
297,091
+40,371
| +16% | +$2.31M | 0.3% | 55 |
|
|
2014
Q4 | $13.7M | Sell |
256,720
-10,556
| -4% | -$591K | 0.26% | 75 |
|
|
2014
Q3 | $15.4M | Sell |
267,276
-9,113
| -3% | -$559K | 0.31% | 52 |
|
|
2014
Q2 | $18.5M | Buy |
276,389
+43,971
| +19% | +$2.98M | 0.26% | 75 |
|
|
2014
Q1 | $15.5M | Buy |
232,418
+34,507
| +17% | +$2.33M | 0.24% | 91 |
|
|
2013
Q4 | $13.2M | Buy |
197,911
+19,789
| +11% | +$1.28M | 0.22% | 117 |
|
|
2013
Q3 | $11.2M | Buy |
178,122
+14,300
| +9% | +$921K | 0.21% | 134 |
|
|
2013
Q2 | $10.2M | Buy |
+163,822
| New | +$10.4M | 0.2% | 141 |
|
Other funds holding GSK
JEST
